2013白血病·淋巴瘤Requires access

Study on myelodysplastic syndrome lymphocyte subsets characteristics and the effects of cyclosporin A

Wenwen Li, Zengsheng Wang, Xiaomin Wang, Yan Li, Min Mao, Xiaoyan Zhang, Aisimutula Aihemaitijiang

Open publisher page 0 citations

Abstract

Objective To analysis the T lymphocyte subsets distribution of patients with myelodysplastic syndrome (MDS)-RA and-RCMD,assess the immune status of MDS patients,and analysis the effects of cyclosporine on T lymphocyte subsets.Methods Using flow cytometry (FCM) on MDS-RA and -RCMD patients and 13 normal controls peripheral blood samples for T lymphocyte subsets,detection of patients with RA and RCMD lymphocyte subsets before and after 6 months of treatment in the application of cyclosporine-based immunosuppressive regimen.Results The MDS group Th cells (CD; CD;),Th/Ts ratio were lower than those in normal control group (t =13.39,3.64,all P < 0.05).Ts cells (CD3+ CD8+) express higher than that in normal control group [(29.07±3.88) % vs (21.80±3.63) %] (t =6.47,P < 0.05).Before and after treatment of Th cells,Th / Ts ratio,Ts cells of T lymphocyte subset were significant difference [(35.72±5.02) %,(29.07±3.88) %,(1.89±0.51) % vs (38.19±4.98) %,(26.03±3.03) %,(1.96±0.35)%] (t =0.39,2.65,3.57,all P < 0.05).Cyclosporine treatment after 6 months of effective and ineffective group of T cell subsets,Th cells (CD3+ CD4+),Th/Ts ratio of T lymphocyte subsets,there was significant difference in Ts cells [(42.79±7.74) % vs (36.46±.1.28) %,(22.14±.3.91) % vs (27.51±2.84) %,(2.40±0.40) % vs (2.08±0.11) %](t =67.65,3.77,3.57,all P < 0.05).Conclusion MDS patients with T-lymphocyte subsets immune disorders lead to immune dysfunction,cyclosporine may improve the imbalance of T lymphocyte subsets of MDS patients. Key words: Myelodysplastic syndromes;  T lymphocytes;  Cyclosporine

About this research paper

What this paper is about

Objective To analysis the T lymphocyte subsets distribution of patients with myelodysplastic syndrome (MDS)-RA and-RCMD,assess the immune status of MDS patients,and analysis the effects of cyclosporine on T lymphocyte subsets.Methods Using flow cytometry (FCM) on MDS-RA and -RCMD patients and 13 normal controls peripheral blood samples for T lymphocyte subsets,detection of patients with RA and RCMD lymphocyte subsets before and after 6 months of treatment in the application of cyclosporine-based immunosuppressive regimen.Results The MDS group Th cells (CD; CD;),Th/Ts ratio were lower than those in normal control group (t =13.39,3.64,all P < 0.05).Ts cells (CD3+ CD8+) express higher than that in normal control group [(29.07±3.88) % vs (21.80±3.63) %] (t =6.47,P < 0.05).Before and after treatment of Th cells,Th / Ts ratio,Ts cells of T lymphocyte subset were significant difference [(35.72±5.02) %,(29.07±3.88) %,(1.89±0.51) % vs (38.19±4.98) %,(26.03±3.03) %,(1.96±0.35)%] (t =0.39,2.65,3.57,all P < 0.05).Cyclosporine treatment after 6 months of effective and ineffective group of T cell subsets,Th cells (CD3+ CD4+),Th/Ts ratio of T lymphocyte subsets,there was significant difference in Ts cells [(42.79±7.74) % vs (36.46±.1.28) %,(22.14±.3.91) % vs (27.51±2.84) %,(2.40±0.40) % vs (2.08±0.11) %](t =67.65,3.77,3.57,all P < 0.05).Conclusion MDS patients with T-lymphocyte subsets immune disorders lead to immune dysfunction,cyclosporine may improve the imbalance of T lymphocyte subsets of MDS patients. Key words: Myelodysplastic syndromes;  T lymphocytes;  Cyclosporine

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analysis the T lymphocyte subsets distribution of patients with myelodysplastic syndrome (MDS)-RA and-RCMD,assess the immune status of MDS patients,and analysis the effects of cyclosporine on T lymphocyte subsets.Methods Using flow cytometry (FCM) on MDS-RA and -RCMD patients and 13 normal controls peripheral blood samples for T lymphocyte subsets,detection of patients with RA and RCMD lymphocyte subsets before and after 6 months of treatment in the application of cyclosporine-based immunosuppressive regimen.Results The MDS group Th cells (CD; CD;),Th/Ts ratio were lower than those in normal control group (t =13.39,3.64,all P < 0.05).Ts cells (CD3+ CD8+) express higher than that in normal control group [(29.07±3.88) % vs (21.80±3.63) %] (t =6.47,P < 0.05).Before and after treatment of Th cells,Th / Ts ratio,Ts cells of T lymphocyte subset were significant difference [(35.72±5.02) %,(29.07±3.88) %,(1.89±0.51) % vs (38.19±4.98) %,(26.03±3.03) %,(1.96±0.35)%] (t =0.39,2.65,3.57,all P < 0.05).Cyclosporine treatment after 6 months of effective and ineffective group of T cell subsets,Th cells (CD3+ CD4+),Th/Ts ratio of T lymphocyte subsets,there was significant difference in Ts cells [(42.79±7.74) % vs (36.46±.1.28) %,(22.14±.3.91) % vs (27.51±2.84) %,(2.40±0.40) % vs (2.08±0.11) %](t =67.65,3.77,3.57,all P < 0.05).Conclusion MDS patients with T-lymphocyte subsets immune disorders lead to immune dysfunction,cyclosporine may improve the imbalance of T lymphocyte subsets of MDS patients. Key words: Myelodysplastic syndromes;  T lymphocytes;  Cyclosporine

Key concepts: CD8, Lymphocyte subsets, Medicine, Internal medicine, Lymphocyte, CD3, Gastroenterology, Immune system

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on myelodysplastic syndrome lymphocyte subsets characteristics and the effects of cyclosporin A — Research Paper | ScholarLens